...
首页> 外文期刊>Stem cells and development >Heat shock protein-90 beta is expressed at the surface of multipotential mesenchymal precursor cells: generation of a novel monoclonal antibody, STRO-4, with specificity for mesenchymal precursor cells from human and ovine tissues.
【24h】

Heat shock protein-90 beta is expressed at the surface of multipotential mesenchymal precursor cells: generation of a novel monoclonal antibody, STRO-4, with specificity for mesenchymal precursor cells from human and ovine tissues.

机译:热休克蛋白90β在多能间充质前体细胞的表面表达:一种新型单克隆抗体STRO-4的产生,对人和绵羊组织的间充质前体细胞具有特异性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Mesenchymal stromal cells (MSCs) and their precursor cells (MPCs) can proliferate and differentiate into multiple mesodermal and some ectodermal and endodermal tissues. Culture-expanded MSCs are currently being evaluated as a possible cell therapy to replace/repair injured or diseased tissues. While a number of mAb reagents with specificity to human MSCs, including STRO-1, STRO-3 (BLK ALP), CD71 (SH2, SH3), CD106 (VCAM-1), CD166, and CD271, have facilitated the isolation of purified populations of human MSCs from primary tissues, few if any mAb reagents have been described that can be used to isolate equivalent cells from other species. This is of particular relevance when assessing the tissue regenerative efficacy of MSCs in large immunocompetent, preclinical animal models of disease. In light of this, we sought to generate novel monoclonal antibodies (mAb) with specific reactivity against a cell surface molecule that is expressed at high levels by MSCs from different species. Using CD106 (VCAM-1)-selected ovine MSCs as an immunogen, mAb-producing hybridomas were selected for their reactivity to both human and ovine MSCs. One such hybridoma, termed STRO-4, produced an IgG mAb that reacted with <5% of human and ovine bone marrow (BM) mononuclear cells. As a single selection reagent, STRO-4 mAb was able to enrich colony-forming fibroblasts (CFU-F) in both human and ovine BM by 16- and 8-folds, respectively. Cells isolated with STRO-4 exhibited reactivity with markers commonly associated with MSCs isolated by plastic adherence including CD29, CD44, and CD166. Moreover, when placed in inductive culture conditions in vitro, STRO-4(+) MSCs exhibited multilineage differentiation potential and were capable of forming a mineralized matrix, lipid-filled adipocytes, and chondrocytes capable of forming a glycosaminoglycan-rich matrix. Biochemical analysis revealed that STRO-4 identified the beta isoform of heat shock protein-90 (Hsp90beta). In addition to identifying an antibody reagent that identifies a highly conserved epitope expressed by MSCs from different species, our study also points to a potential role for Hsp90beta in MSC biology.
机译:间充质基质细胞(MSC)及其前体细胞(MPC)可以增殖并分化为多种中胚层以及一些外胚层和内胚层组织。目前正在评估培养物扩增的MSCs作为可能的细胞疗法,以替换/修复受伤或患病的组织。虽然许多对人类MSC具特异性的mAb试剂,包括STRO-1,STRO-3(BLK ALP),CD71(SH2,SH3),CD106(VCAM-1),CD166和CD271,都有助于分离纯化的从原代组织中获得的人类MSC数量众多,目前几乎没有描述可用于从其他物种中分离等效细胞的mAb试剂。在评估大型免疫能力强的临床前动物疾病模型中MSC的组织再生功效时,这特别相关。有鉴于此,我们寻求产生对细胞表面分子具有特异性反应性的新型单克隆抗体(mAb),该细胞表面分子由不同物种的MSC高水平表达。使用CD106(VCAM-1)选择的绵羊MSC作为免疫原,选择产生mAb的杂交瘤对人和绵羊MSC都具有反应性。一种称为STRO-4的杂交瘤产生了IgG mAb,它与<5%的人和绵羊骨髓(BM)单核细胞反应。作为单一选择试剂,STRO-4 mAb能够使人和绵羊BM中的集落形成成纤维细胞(CFU-F)分别富集16倍和8倍。用STRO-4分离的细胞表现出与通常与通过塑料粘附分离的MSC相关的标志物的反应性,包括CD29,CD44和CD166。此外,当放置在体外诱导培养条件下时,STRO-4(+)MSCs表现出多系分化潜能,并且能够形成矿化基质,脂质填充的脂肪细胞和软骨细胞,能够形成富含糖胺聚糖的基质。生化分析表明,STRO-4鉴定出了热激蛋白90(Hsp90beta)的β亚型。除了鉴定可识别不同物种的MSC表达的高度保守表位的抗体试剂外,我们的研究还指出了Hsp90beta在MSC生物学中的潜在作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号